(Bloomberg) — Stocks are falling and bond yields are rising, but markets still don’t seem convinced the Federal Reserve will pursue plans to keep increasing interest rates until inflation is under control, said Sonal Desai, chief investment officer for fixed income at Franklin Templeton Cos. “The Fed lacks credibility,” Desai said on Bloomberg Television’s “Wall […]
Read More(Bloomberg) — The S&P 500 Index still hasn’t bottomed yet despite its 7% plunge over the last three weeks, according to a group of strategists at Bank of America Corp. led by Savita Subramanian. The bank’s so-called bull-market signposts suggest the broad US equities benchmark hasn’t reached full capitulation, with just 40% of BofA’s signals […]
Read MoreCogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal […]
Read MoreCHS Inc. (CHSCP) CHS Inc., an integrated agricultural company, provides grains, foods, and energy resources to businesses and consumers in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Energy, Ag, Nitrogen Production, and Foods. BrasilAgro – Companhia Brasileira de Propriedades Agrícolas (LND) BrasilAgro – […]
Read MoreVista Energy, S.A.B. de C.V. (VIST) Vista Energy, S.A.B. de C.V., through its subsidiaries, engages in the exploration and production of oil and gas in Latin America. The company’s principal assets are located in Vaca Muerta with approximately 183, 100 acres. It also owns producing assets in Argentina and Mexico. Cytokinetics, Incorporated (CYTK) Cytokinetics, Incorporated, […]
Read MoreBuy Price: $12.30 or better Sell Price: TradersPro Sell Signal BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of […]
Read MoreContrarian investors and bargain hunters tend to think quite a bit differently about stock price movements and trends than growth-focused investors. When everybody is buying, we tend to get more cautious, and when everybody is running for the exits, we start finding more and more attractive opportunities at great prices. 2022 has been a rough […]
Read More(Bloomberg) — Investors bracing for a recession jolt accelerated their retreat from stocks after the Federal Reserve warned it won’t be easily deterred in its fight against inflation, Bank of America Corp. strategists say. Global equity funds had outflows of $9.4 billion in the week to Aug. 31, the fourth-largest redemptions this year, according to […]
Read More